ANCA Vasculitis: Wegener's Granulomatosis, NF-kB, and Ginger

ANCA-associated vasculitides (Anti-Neutrophil Cytoplasmic Antibody) primarily include granulomatosis with polyangiitis (GPA, formerly Wegener's disease), microscopic polyangiitis (MPA), and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss). These are rare but potentially life-threatening diseases, affecting the kidneys, lungs, and nervous system.

Mechanisms of ANCA Vasculitis: The Central Role of NF-kB

ANCAs (anti-PR3 in GPA, anti-MPO in MPA) are autoantibodies that directly activate neutrophils:

1. Neutrophils primed by cytokines (TNF-α, IL-18) express PR3 and MPO on their surface
2. ANCAs bind to these antigens → neutrophil activation → NETosis (release of NETs laden with DNA and PR3/MPO)
3. NETs activate endothelial cells → NF-kB → expression of adhesion molecules and cytokines → recruitment of polymorphonuclear cells and monocytes
4. Perivascular granulomas → tissue destruction (kidneys, lungs, ENT, nerves)
5. IL-17A (Th17): amplifies neutrophil recruitment and ANCA production

Gingerol and the Mechanisms of ANCA Vasculitis

Several targets of gingerol are relevant in ANCA vasculitis:

• Inhibition of NETosis: gingerol reduces the release of NETs by activated neutrophils (Inflammation Research, 2021) — directly relevant in ANCA vasculitis where NETosis is central
• Inhibition of endothelial NF-kB: ↓ VCAM-1, ICAM-1, E-selectin → less neutrophil recruitment into the vascular wall
• Anti-Th17: ↓ IL-17A via inhibition of RORγt and STAT3 → less amplification of neutrophil recruitment
• Reduction of TNF-α: TNF-α is the cytokine that primes neutrophils for ANCA activation — gingerol reduces TNF-α by 40-70%

Essential Clinical Stance

ANCA vasculitis are life-threatening diseases. Induction treatment relies on rituximab or cyclophosphamide + corticosteroids. INTI is not a treatment for ANCA vasculitis — it is potentially a very modest adjuvant in the maintenance phase. Caution is absolutely necessary: patients on immunosuppressants must discuss any supplements with their nephrologist/rheumatologist.

Practical Note

ANCA patients in maintenance on azathioprine or rituximab often have dietary and metabolic restrictions. INTI, with 1.19g of sugar per 100ml and its natural anti-inflammatory ginger profile, is compatible with most protocols, subject to medical validation. GIMBER, with 35g/100ml, should be avoided, especially in cases of associated cortico-ginger diabetes.

Conclusion

ANCA vasculitis involves NF-kB, NETosis, Th17, and TNF-α — all targets of gingerol. While specific clinical data are lacking, the mechanistic consistency is real. INTI can be considered as a general anti-inflammatory supplement in the maintenance phase, with prior medical validation.

Strictly informative article. ANCA vasculitis requires specialized immunosuppressive treatment. Consult your nephrologist or rheumatologist before any supplement.